- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-06-0003973

About Menrik Biomerge Private Limited
Data last updated:
Menrik Biomerge Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2017PTC317030. Its GSTIN is 07AALCM0374K2Z6 (Delhi). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Vibhor Rastogi and Ketan Swaroop Bansal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 5 Ground Floor, Manak Vihar Opp. Yojna Vihar, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.52 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹6.73 Lakh (net margin 0.5%) and EBITDA of ₹18.53 Lakh (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 17% over five years.
The company is associated with 1 brand: Menrik Biomerge. As per MCA filings, the company has open charges of ₹95 Lakh on record. Court records list 10 cases involving the company, including 7 filed by the company and 3 filed against it; 3 cases are pending.
Menrik Biomerge Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0003973). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website menrik.com.
Company details
Recognitions & Rankings of Menrik Biomerge
Contact details
Menrik Biomerge Private Limited's registered office is in New Delhi, Delhi. Its website is menrik.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address5 Ground Floor, Manak Vihar Opp. Yojna Vihar, New Delhi, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Menrik Biomerge Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Menrik Biomerge operates one associated brand: Menrik Biomerge. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical, cosmetics, and nutraceutical manufacturing and distribution services. | menrik.com |
Business activity
The main business activity of Menrik Biomerge is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Menrik Biomerge Private Limited, buy the company report.
Financials of Menrik Biomerge Private Limited
FY 2024 filings availableMenrik Biomerge Private Limited reported revenue of ₹13.52 Cr (up 4% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 4% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.73 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Menrik Biomerge Private Limited, buy the company report.
Board of directors of Menrik Biomerge Private Limited
Menrik Biomerge has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vibhor Rastogi | Director | 01 May 2017 | 9 Years 6 Months | Current |
| Ketan Swaroop Bansal | Director | 01 May 2017 | 9 Years 6 Months | Current |
Peer comparison
Menrik Biomerge Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| M Sea Pharmaceuticals Private Limited | ₹13.67 Cr (FY 2024) | -3.0% | Himachal Pradesh, India | |||
| Chaitanya Life Science Private Limited | ₹13.59 Cr (FY 2024) | 364.0% | Jhagadia, Gujarat, India | |||
| Caplet Health Care Private Limited | ₹13.53 Cr (FY 2025) | 11.0% | Kolkata, West Bengal, India | |||
| Menrik Biomerge Private Limitedthis company | ₹13.52 Cr (FY 2024) | ₹6.73 Lakh | 0.5% | 4.0% | New Delhi, Delhi, India | |
| Dhwanilife Care Private Limited | ₹13.5 Cr (FY 2024) | 85.0% | Ahmedabad, Gujarat, India | |||
| KNM Pharma Private Limited | ₹13.41 Cr (FY 2025) | 36.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Menrik Biomerge Private Limited, buy the company report.
Auditor
Menrik Biomerge Private Limited is audited by Jitender R Deo & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Jitender R Deo & Company | FY 2023 | 019127N |
Shareholding
The shareholding of Menrik Biomerge Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Menrik Biomerge Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2018 | 100241714 | Others | ₹95 Lakh | Open |
To see the full charge records of Menrik Biomerge Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Menrik Biomerge Private Limited has 10 court cases on record: 7 filed by Menrik Biomerge, 3 filed against it. 3 cases are pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 0 | 3 |
| High courts | 3 | 3 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Procter and Gamble Health Limited | Disposed |
| High Court | Interim or miscellaneous application | Filed against the company by Procter and Gamble Health Limited and 1 other | Disposed |
| High Court | Court case (COMIP) | Filed against the company by Procter and Gamble Health Limited and 1 other | Disposed |
| District court, Shahdara, Delhi | Cheque dishonour complaint | Filed by the company against M/S Swisskem India and 1 other | Pending |
| District court, Shahdara, Delhi | Cheque dishonour complaint | Filed by the company against M/S Merit Healthcare and 1 other | Pending |
To see the full case history of Menrik Biomerge Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Menrik Biomerge Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Menrik Biomerge has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AALCM0374K2Z6 | Delhi | Active | 01 Nov 2018 |
| 05AALCM0374K1ZB | Uttarakhand | Active | 27 Jul 2017 |
To see the full GST registrations and return filing status of Menrik Biomerge Private Limited, buy the company report.
Recent activity
Menrik Biomerge Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Ketan Swaroop Bansal was appointed as Director on 01 May 2017.
Frequently asked questions
Menrik Biomerge is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 May 2017 (9+ years old) and is registered under CIN U24304DL2017PTC317030.
Menrik Biomerge has 2 current directors:
- Vibhor Rastogi - Director
- Ketan Swaroop Bansal - Director
The latest financial statements of Menrik Biomerge on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Menrik Biomerge is 07AALCM0374K2Z6, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 05AALCM0374K1ZB (Uttarakhand).
The CIN (Corporate Identification Number) of Menrik Biomerge is U24304DL2017PTC317030. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Menrik Biomerge has 10 court cases on record: 7 filed by the company and 3 filed against it. 3 are pending. Most are in the district courts.
Menrik Biomerge was incorporated on 01 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Menrik Biomerge by revenue are M Sea Pharmaceuticals Private Limited, Chaitanya Life Science Private Limited, Caplet Health Care Private Limited, Dhwanilife Care Private Limited, KNM Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ketan Swaroop Bansal was appointed as Director on 01 May 2017. Vibhor Rastogi was appointed as Director on 01 May 2017.
Yes, Menrik Biomerge is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0003973).
Menrik Biomerge can be reached through the website menrik.com. Its registered office is in New Delhi, Delhi, India.

